Growth velocity monitoring of the efficacy of different therapeutic protocols in a group of thalassaemic children
Since intensive chelating therapy for thalassaemic children was introduced, growth rates appear to have diminished. To investigate what factors were responsible we compared velocities of growth in length over a period of 1 year between groups distinguished by different strategies of treatment. Forty...
Gespeichert in:
| Veröffentlicht in: | European journal of pediatrics 1995-03, Vol.154 (3), p.205-208 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 208 |
|---|---|
| container_issue | 3 |
| container_start_page | 205 |
| container_title | European journal of pediatrics |
| container_volume | 154 |
| creator | Benso, L Gambotto, S Pastorin, L Signorile, F Tanner, J M |
| description | Since intensive chelating therapy for thalassaemic children was introduced, growth rates appear to have diminished. To investigate what factors were responsible we compared velocities of growth in length over a period of 1 year between groups distinguished by different strategies of treatment. Forty-two thalassaemic patients, 30 males aged 4-12 years, and 12 females, 4-10 years old, were assigned from their current treatment into subgroups based upon blood ferritin levels, daily dose of desferrioxamine and urinary zinc levels. CONCLUSION The results confirm that a reduction in desferrioxamine results in greater growth. If blood ferritin is low, the change effect may be greater. Secondly, any zinc deficiency should be treated. The changes in treatment convert a growth velocity of -2 to -3 SDS to a velocity of about -1 SDS. |
| doi_str_mv | 10.1007/BF01954272 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77286381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77286381</sourcerecordid><originalsourceid>FETCH-LOGICAL-c197t-ee2e494bc8c940c68e1107b8cae97623e40110b448d7342695e39fda508c7fdb3</originalsourceid><addsrcrecordid>eNpFkDFPwzAQhS0EKqWwsCN5YkAK2LET2yNUtCBVYoE5cpxza5TExXZA_fekagXT6e6-93T3ELqm5J4SIh6eFoSqguciP0FTylmeUSLKUzQljJOspEqdo4sYP8kIKyonaCJEIQsqp-hrGfxP2uBvaL1xaYc737vkg-vX2FucNoDBWme02e37xlkLAfq03wS9hSE5g7fBJ298G7Hrscbr4IftQa1bHaOGboTMxrXNKL1EZ1a3Ea6OdYY-Fs_v85ds9bZ8nT-uMkOVSBlADlzx2kijODGlBDo-VUujQYkyZ8DJOKg5l41gPC9VAUzZRhdEGmGbms3Q7cF3vO5rgJiqzkUDbat78EOshMhlySQdwbsDaIKPMYCttsF1OuwqSqp9vtV_viN8c3Qd6g6aP_QYKPsFRFt23w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77286381</pqid></control><display><type>article</type><title>Growth velocity monitoring of the efficacy of different therapeutic protocols in a group of thalassaemic children</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Benso, L ; Gambotto, S ; Pastorin, L ; Signorile, F ; Tanner, J M</creator><creatorcontrib>Benso, L ; Gambotto, S ; Pastorin, L ; Signorile, F ; Tanner, J M</creatorcontrib><description>Since intensive chelating therapy for thalassaemic children was introduced, growth rates appear to have diminished. To investigate what factors were responsible we compared velocities of growth in length over a period of 1 year between groups distinguished by different strategies of treatment. Forty-two thalassaemic patients, 30 males aged 4-12 years, and 12 females, 4-10 years old, were assigned from their current treatment into subgroups based upon blood ferritin levels, daily dose of desferrioxamine and urinary zinc levels. CONCLUSION The results confirm that a reduction in desferrioxamine results in greater growth. If blood ferritin is low, the change effect may be greater. Secondly, any zinc deficiency should be treated. The changes in treatment convert a growth velocity of -2 to -3 SDS to a velocity of about -1 SDS.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/BF01954272</identifier><identifier>PMID: 7758518</identifier><language>eng</language><publisher>Germany</publisher><subject>Chelation Therapy ; Child ; Child, Preschool ; Chronic Disease ; Deferoxamine - administration & dosage ; Female ; Ferritins - blood ; Follow-Up Studies ; Growth ; Humans ; Male ; Thalassemia - blood ; Thalassemia - drug therapy ; Thalassemia - physiopathology ; Zinc - urine</subject><ispartof>European journal of pediatrics, 1995-03, Vol.154 (3), p.205-208</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c197t-ee2e494bc8c940c68e1107b8cae97623e40110b448d7342695e39fda508c7fdb3</citedby><cites>FETCH-LOGICAL-c197t-ee2e494bc8c940c68e1107b8cae97623e40110b448d7342695e39fda508c7fdb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7758518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Benso, L</creatorcontrib><creatorcontrib>Gambotto, S</creatorcontrib><creatorcontrib>Pastorin, L</creatorcontrib><creatorcontrib>Signorile, F</creatorcontrib><creatorcontrib>Tanner, J M</creatorcontrib><title>Growth velocity monitoring of the efficacy of different therapeutic protocols in a group of thalassaemic children</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><description>Since intensive chelating therapy for thalassaemic children was introduced, growth rates appear to have diminished. To investigate what factors were responsible we compared velocities of growth in length over a period of 1 year between groups distinguished by different strategies of treatment. Forty-two thalassaemic patients, 30 males aged 4-12 years, and 12 females, 4-10 years old, were assigned from their current treatment into subgroups based upon blood ferritin levels, daily dose of desferrioxamine and urinary zinc levels. CONCLUSION The results confirm that a reduction in desferrioxamine results in greater growth. If blood ferritin is low, the change effect may be greater. Secondly, any zinc deficiency should be treated. The changes in treatment convert a growth velocity of -2 to -3 SDS to a velocity of about -1 SDS.</description><subject>Chelation Therapy</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Chronic Disease</subject><subject>Deferoxamine - administration & dosage</subject><subject>Female</subject><subject>Ferritins - blood</subject><subject>Follow-Up Studies</subject><subject>Growth</subject><subject>Humans</subject><subject>Male</subject><subject>Thalassemia - blood</subject><subject>Thalassemia - drug therapy</subject><subject>Thalassemia - physiopathology</subject><subject>Zinc - urine</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkDFPwzAQhS0EKqWwsCN5YkAK2LET2yNUtCBVYoE5cpxza5TExXZA_fekagXT6e6-93T3ELqm5J4SIh6eFoSqguciP0FTylmeUSLKUzQljJOspEqdo4sYP8kIKyonaCJEIQsqp-hrGfxP2uBvaL1xaYc737vkg-vX2FucNoDBWme02e37xlkLAfq03wS9hSE5g7fBJ298G7Hrscbr4IftQa1bHaOGboTMxrXNKL1EZ1a3Ea6OdYY-Fs_v85ds9bZ8nT-uMkOVSBlADlzx2kijODGlBDo-VUujQYkyZ8DJOKg5l41gPC9VAUzZRhdEGmGbms3Q7cF3vO5rgJiqzkUDbat78EOshMhlySQdwbsDaIKPMYCttsF1OuwqSqp9vtV_viN8c3Qd6g6aP_QYKPsFRFt23w</recordid><startdate>199503</startdate><enddate>199503</enddate><creator>Benso, L</creator><creator>Gambotto, S</creator><creator>Pastorin, L</creator><creator>Signorile, F</creator><creator>Tanner, J M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199503</creationdate><title>Growth velocity monitoring of the efficacy of different therapeutic protocols in a group of thalassaemic children</title><author>Benso, L ; Gambotto, S ; Pastorin, L ; Signorile, F ; Tanner, J M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c197t-ee2e494bc8c940c68e1107b8cae97623e40110b448d7342695e39fda508c7fdb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Chelation Therapy</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Chronic Disease</topic><topic>Deferoxamine - administration & dosage</topic><topic>Female</topic><topic>Ferritins - blood</topic><topic>Follow-Up Studies</topic><topic>Growth</topic><topic>Humans</topic><topic>Male</topic><topic>Thalassemia - blood</topic><topic>Thalassemia - drug therapy</topic><topic>Thalassemia - physiopathology</topic><topic>Zinc - urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Benso, L</creatorcontrib><creatorcontrib>Gambotto, S</creatorcontrib><creatorcontrib>Pastorin, L</creatorcontrib><creatorcontrib>Signorile, F</creatorcontrib><creatorcontrib>Tanner, J M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Benso, L</au><au>Gambotto, S</au><au>Pastorin, L</au><au>Signorile, F</au><au>Tanner, J M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Growth velocity monitoring of the efficacy of different therapeutic protocols in a group of thalassaemic children</atitle><jtitle>European journal of pediatrics</jtitle><addtitle>Eur J Pediatr</addtitle><date>1995-03</date><risdate>1995</risdate><volume>154</volume><issue>3</issue><spage>205</spage><epage>208</epage><pages>205-208</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><abstract>Since intensive chelating therapy for thalassaemic children was introduced, growth rates appear to have diminished. To investigate what factors were responsible we compared velocities of growth in length over a period of 1 year between groups distinguished by different strategies of treatment. Forty-two thalassaemic patients, 30 males aged 4-12 years, and 12 females, 4-10 years old, were assigned from their current treatment into subgroups based upon blood ferritin levels, daily dose of desferrioxamine and urinary zinc levels. CONCLUSION The results confirm that a reduction in desferrioxamine results in greater growth. If blood ferritin is low, the change effect may be greater. Secondly, any zinc deficiency should be treated. The changes in treatment convert a growth velocity of -2 to -3 SDS to a velocity of about -1 SDS.</abstract><cop>Germany</cop><pmid>7758518</pmid><doi>10.1007/BF01954272</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0340-6199 |
| ispartof | European journal of pediatrics, 1995-03, Vol.154 (3), p.205-208 |
| issn | 0340-6199 1432-1076 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77286381 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Chelation Therapy Child Child, Preschool Chronic Disease Deferoxamine - administration & dosage Female Ferritins - blood Follow-Up Studies Growth Humans Male Thalassemia - blood Thalassemia - drug therapy Thalassemia - physiopathology Zinc - urine |
| title | Growth velocity monitoring of the efficacy of different therapeutic protocols in a group of thalassaemic children |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A31%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Growth%20velocity%20monitoring%20of%20the%20efficacy%20of%20different%20therapeutic%20protocols%20in%20a%20group%20of%20thalassaemic%20children&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=Benso,%20L&rft.date=1995-03&rft.volume=154&rft.issue=3&rft.spage=205&rft.epage=208&rft.pages=205-208&rft.issn=0340-6199&rft.eissn=1432-1076&rft_id=info:doi/10.1007/BF01954272&rft_dat=%3Cproquest_cross%3E77286381%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77286381&rft_id=info:pmid/7758518&rfr_iscdi=true |